(Q40875079)

24 September 2017

1 reference

title

Hormone-replacement therapy in patients with breast cancer. A reappraisal (English)

1 reference

Hormone Replacement Therapy

24 September 2017

main subject

1 reference

1

DiSaia PJ

0 references

language of work or name

English

0 references

publication date

1 February 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

71

1 reference

24 September 2017

issue

4 Suppl

1 reference

24 September 2017

page(s)

1490-1500

1 reference

The pharmacology and clinical uses of tamoxifen

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Antiestrogens in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Hormones and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

CARCINOMA OF THE BREAST RESULTS OF SURGICAL TREATMENT WHEN THE CARCINOMA OCCURRED IN THE COURSE OF PREGNANCY OR LACTATION AND WHEN PREGNANCY OCCURRED SUBSEQUENT TO OPERATION (1910-1933)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Carcinoma of the Breast Associated with Pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Carcinoma of the breast in women under 30 years of age: a clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958-1968

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Breast carcinoma associated with pregnancy: a clinician's dilemma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Breast cancer and pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Carcinoma of the breast and pregnancy; analysis of 920 cases collected from the literature and 22 new cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Treatment of breast tumors associated with pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Pregnancy Subsequent to Mastectomy for Cancer of the Breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Oral contraceptives and breast cancer: final report of an epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Oral contraceptive use has no adverse effect on the prognosis of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Menopausal Estrogens and Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

The impact of long term estrogen support after hysterectomy. A report of 1016 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Exogenous hormones, reproductive history, and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Potential role of tamoxifen in prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Estrogen replacement therapy and protection from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Ovarian function and adjuvant chemotherapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Epidemiology of osteoporosis and osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820710414

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820710414

0 references

1 reference